This is a working overview of ACTH analog, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-08-28. Anything still debated is marked as such rather than presented as settled.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues correspond to the ACTH(4-10) fragment, while the terminal Pro-Gly-Pro extension was added to improve metabolic stability. Its molecular formula is C37H51N9O10S and its monoisotopic mass is approximately 813.9 Da. The compound is classified as a peptide research chemical and as a registered pharmaceutical product in Russia, but it does not hold marketing approval in the European Union or the United States. Naming conventions vary across supplier catalogs.
Development of the compound took place in the Soviet Union during the 1980s, largely through peptide research groups affiliated with the Shemyakin-Ovchinnikov Institute and Moscow State University. Investigators screened fragments of adrenocorticotropic hormone for activity on the central nervous system while attempting to separate cognitive effects from hormonal ones. The shortened sequence was selected because it retained behavioral activity in animal models without stimulating corticosteroid release. Early publications described the molecule as an ACTH(4-10) analog.
Published research on this peptide originates mainly from Russian laboratories, and the wider international literature is comparatively thin. Studies have used rodent models of stroke, hypoxia, and memory tasks, with a smaller number of human trials reported. Reported outcomes include changes in attention and memory measures, along with effects on neurotrophic factor expression in some experiments. Small sample sizes, inconsistent dosing protocols, and limited independent replication are widely noted limitations, so the strength of the clinical evidence remains an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic heptapeptide | Analog of an ACTH fragment |
| Amino acid length | Seven residues | Met-Glu-His-Phe-Pro-Gly-Pro |
| Origin | Moscow, 1980s | Institute of Molecular Genetics |
| Approved regions | Russia and some neighboring states | Not cleared in Western markets |
| Common trade names | Multiple national brands | Sold as a nasal formulation |
Semax is a synthetic seven-amino-acid peptide whose sequence extends the ACTH(4-10) fragment with a C-terminal proline-glycine-proline tripeptide. The commonly cited sequence is Met-Glu-His-Phe-Pro-Gly-Pro, giving a molecular formula near C37H51N9O10S and a molecular weight close to 813.9 g/mol. It belongs to the broader class of synthetic ACTH fragments studied for central nervous system effects rather than for adrenal steroid stimulation. In practice the material appears as a lyophilized white powder for laboratory work or as a dilute saline solution in clinical settings.
Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.
Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.
当时的短肽研究普遍关注能否穿越血脑屏障、在低剂量下产生中枢效应，Semax 属于这一路线。鼻内给药是其主要使用方式，俄语文献报道的适应症涵盖缺血性卒中、短暂性脑缺血发作、认知功能减退以及视神经病变。这些研究大多发表在当地期刊上，样本规模与终点设置同西方试验惯例存在差异，国际同行对其临床证据的强度看法不一。
各国监管态度分化明显。俄罗斯按处方药管理，部分东欧国家留有使用记录；欧盟与美国未批准其作为药物上市，市面流通品通常标注为研究用化学品。身份差异意味着标示含量、纯度与无菌性缺少统一核查。体育领域还牵涉反兴奋剂名录，跨境携带则受目的地药品法规约束。
=== Thorium-228 === 228Th is an isotope of thorium with 138 neutrons. It was once named Radiothorium, due to its occurrence in the disintegration chain of thorium-232. It has a half-life of 1.9125 years. It undergoes alpha decay to 224Ra. Occasionally it decays by the unusual route of cluster decay, emitting a nucleus of 20O and producing stable 208Pb. It is a daughter isotope of 232U and responsible for its radiological hazard. Together with its decay product 224Ra it is used for alpha particle radiation therapy.
This manifests as "electrode saturation", loss of cyclable Ah charge and as a "voltage fade". Other material degradations. Negative copper current collector is particularly prone to corrosion/dissolution at low cell voltages. PVDF binder also degrades, causing the detachment of the electroactive materials, and the loss of cyclable Ah charge.
But a problem arose for the NRL researchers because naval materials, e.g., ship-plate steel, are not perfectly elastic but undergo significant plastic deformation at the tip of a crack. One basic assumption in Irwin's linear elastic fracture mechanics is small scale yielding, the condition that the size of the plastic zone is small compared to the crack length. However, this assumption is quite restrictive for certain types of failure in structural steels though such steels can be prone to brittle fracture, which has led to a number of catastrophic failures. Linear-elastic fracture mechanics is of limited practical use for structural steels and Fracture toughness testing can be expensive.
Sources: en.wikipedia.org
(1978), federal judge of the United States District Court for the District of New Jersey Rolando Acosta (1979), associate justice of the Appellate Division of the New York Supreme Court, First Judicial Department Frank J. Aquila (1979), corporate lawyer, partner at Sullivan & Cromwell Umar Ata Bandial (1979), justice of the Supreme Court of Pakistan and former chief justice of Lahore High Court Lanny A. Breuer (1980), U.S. assistant attorney general for the Criminal Division Ronald Weich (1980), U.S. assistant attorney general for the Office of Legislative Affairs Paul Feinman (1981), judge of the New York Court of Appeals Michael H. Cohen (1983), healthcare law attorney, professor at Harvard Medical School Miguel Estrada (1983), controversial nominee to the United States Court of Appeals for the D.C. Circuit Steven Reich (1983), CEO of Deutsche Bank Trust Company and former associate deputy attorney general 2011–2013 Gary R. Brown (1985), judge of the United States District Court for the Eastern District of New York John H. Chun (1991), judge and nominee to the United States District Court for the Western District of Washington Andrew Ceresney (1993), chair of litigation practice at Debevoise & Plimpton and former head of enforcement at the U.S. Securities and Exchange Commission Veronica S.
== References == 11. Website publication of Silver Book: The Silver Book and the NPU Format for Clinical Laboratory Science Reports Regarding Properties, Units, and Symbols . Published Online: 2017-04-25; Published in Print: 2017-04-25
== Side effects == Clinical studies have found that deramciclane is well-tolerated in humans at dosages ranging between 0.2–150 mg. All reported side effects were mild-moderate with the most common side effect being headache and dizziness. No severe side effects were reported in any clinical trial, and no side effects were found to be dose-dependent. Trial participants showed no significant increases in liver enzyme activity and no changes in ECGs, systolic blood pressure, diastolic blood pressure, HDL cholesterol, or LDL cholesterol levels. Another advantage to deramciclane is that it did not produce any withdrawal effects after long-term studies, like other anxiolytics do.
Sources: en.wikipedia.org
The company has created special donut lines for various events, for example, creating soldier-themed doughnuts for National Doughnut Day on June 1 in Thailand, with funds benefitting military personnel in the country. In June 2013, Mister Donut in Thailand debuted the SushiDo, sushi-themed donuts created as a part of "a special sushi-themed menu." At the time, they had not been added to the menu in Japan or other countries. Options included "sweet donut versions of ebi, tamago, maguro, salmon, with sugary frosting replacing raw fish." For Halloween 2013, Mister Donut introduced Hello Kitty jack-o'-lantern doughnuts in pumpkin or strawberry flavors, as well as other seasonal pumpkin-flavored items, including pumpkin versions of their regular donut. As of 2014, the stores in El Salvador focused on a menu described as more "homey than foreign, offering national staples like pupusas and tamales alongside giant cream-filled doughnuts." There have also been items such as strawberry-glaze donuts. In April 2014, the company launched a croissant-style doughnut, which proved popular.
== Origins of biotechnology == Biotechnology arose from the field of zymotechnology or zymurgy, which began as a search for a better understanding of industrial fermentation, particularly beer. Beer was an important industrial, and not just social, commodity. In late 19th-century Germany, brewing contributed as much to the gross national product as steel, and taxes on alcohol proved to be significant sources of revenue to the government. In the 1860s, institutes and remunerative consultancies were dedicated to the technology of brewing. The most famous was the private Carlsberg Institute, founded in 1875, which employed Emil Christian Hansen, who pioneered the pure yeast process for the reliable production of consistent beer. Less well known were private consultancies that advised the brewing industry. One of these, the Zymotechnic Institute, was established in Chicago by the German-born chemist John Ewald Siebel. The heyday and expansion of zymotechnology came in World War I in response to industrial needs to support the war. Max Delbrück grew yeast on an immense scale during the war to meet 60 percent of Germany's animal feed needs. Compounds of another fermentation product, lactic acid, made up for a lack of hydraulic fluid, glycerol. On the Allied side the Russian chemist Chaim Weizmann used starch to eliminate Britain's shortage of acetone, a key raw material for cordite, by fermenting maize to acetone.
In medicine and pharmacology, an orexin receptor antagonist or orexin antagonist is a drug that inhibits the effect of orexin by acting as a receptor antagonist of one (selective orexin receptor antagonist, SORA) or both (dual orexin receptor antagonist, DORA) of the orexin receptors, OX1 and OX2. Medical applications include treatment of sleep disorders such as insomnia.
Taylor), in the grounds of their Oxford home (1946–47) before moving to a property she purchased in the Oxfordshire village of South Leigh (1947–49). In May 1949, the Thomas family moved back to Laugharne into The Boat House, purchased by Margaret Taylor on their behalf. In 1951 Taylor purchased a second property in Camden Town, North London on their behalf where they stayed from October 1951 – January 1952. Caitlin Thomas's autobiographies, Leftover Life to Kill (1957) and My Life with Dylan Thomas: Double Drink Story (1997), describe the effects of alcohol on their relationship: "Ours was not only a love story, it was a drink story, because without alcohol it would never had got on its rocking feet", she wrote, and "The bar was our altar." Biographer Andrew Lycett describes the relationship as one of alcoholic co-dependency and notes how deeply Caitlin resented her husband's numerous extramarital affairs. Dylan and Caitlin Thomas had three children: Llewelyn Edouard (1939–2000), Aeronwy Thomas-Ellis (1943–2009) and Colm Garan Hart (1949–2012). Llewelyn and Aeronwy were privately educated, at the Magdalen College School, Oxford and at the Arts Education School in Tring, Hertfordshire, respectively.
Sources: en.wikipedia.org
It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.
It is registered as a medicine in Russia and has been used clinically there for decades. No regulatory agency in Western Europe or North America has approved it for any indication.
Semax corresponds to the four-to-ten fragment of adrenocorticotropic hormone. Because it omits the first three residues, it lacks the adrenal-stimulating action of the full hormone.
It is a synthetic peptide of seven amino acids. Its backbone corresponds to a fragment of adrenocorticotropic hormone extended at the carboxyl end. The material is distributed as a lyophilized solid for laboratory use.